Access to ‘affordable healthcare’ surges in national priorities amid delays to HTA reforms

Access to “quality affordable” healthcare has emerged as the second most important national priority for Australians, just behind the cost of living. This sentiment spans across metropolitan and regional areas, various demographics and all states. The urgency is deepened by troubling remarks from the PBAC and MSAC Chairs raising doubts over the implementation of the HTA Review reforms.

The Mood of the Nation survey reveals that only 37% of Australians believe the country is heading in the right direction. Nearly three-quarters of Australians (74%) argue that the government should subsidise the best medicines available, even if it means additional costs to taxpayers.

Medicines Australia CEO Liz de Somer commented on the survey findings, saying “This survey shows Australians want to see more investment in the PBS. We know Australians are very concerned about their health today, as it links to their employment, financial security, and quality of life.

“The Mood of the Nation survey shows a higher number of Australians are very concerned about access to medicines, and more people are realising our Pharmaceutical Benefits Scheme and the systems that sit behind are not keeping pace with medical advances.”

The survey also revealed that more than half of Australians (57%) prioritise access to the most appropriate form of medication based on their individual needs. Around one in five (18%) consider access to the latest medicines as their top priority. However, 11% of respondents reported being unable to access the medicine they need through the PBS.

De Somer further emphasised the need for a shift in perspective from policymakers, saying “Policy makers need to start viewing the Pharmaceutical Benefits Scheme as an investment in health, wellbeing, and productivity.

“We need to look at the productivity gains medicines offer, potential savings in other areas of the health system, and the full impact of those gains on society when determining if medicine should be made available on the PBS. This includes how we assess and value different forms of medicines.”

She further added, “Australians believe it is reasonable to expect to be able to access the most appropriate medicine available for their condition when they need it. It’s clear taxpayers want to see more investment in healthcare and medicines and want to see new medicines subsidised faster.”

The growing discontent over the pace of health technology advancements and the ongoing limitations of the PBS highlight a stark reality: Australians are calling for a healthcare system that keeps up with innovation and ensures timely access to the best possible treatments now.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.